Rapid SARS-CoV-2 antigen detection assay in comparison with real-time RT-PCR assay for laboratory diagnosis of COVID-19

  • PDF / 911,147 Bytes
  • 7 Pages / 595.276 x 790.866 pts Page_size
  • 87 Downloads / 171 Views

DOWNLOAD

REPORT


Open Access

RESEARCH

Rapid SARS‑CoV‑2 antigen detection assay in comparison with real‑time RT‑PCR assay for laboratory diagnosis of COVID‑19 in Thailand Chutikarn Chaimayo1, Bualan Kaewnaphan1, Nattaya Tanlieng1, Niracha Athipanyasilp1, Rujipas Sirijatuphat2, Methee Chayakulkeeree2, Nasikarn Angkasekwinai2, Ruengpung Sutthent1, Nattawut Puangpunngam3, Theerawoot Tharmviboonsri4, Orawan Pongraweewan5, Suebwong Chuthapisith3, Yongyut Sirivatanauksorn3, Wannee Kantakamalakul1 and Navin Horthongkham1* 

Abstract  Background:  The Coronavirus disease 2019 (COVID-19) pandemic continues to spread across the world. Hence, there is an urgent need for rapid, simple, and accurate tests to diagnose severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Performance characteristics of the rapid SARS-CoV-2 antigen detection test should be evaluated and compared with the gold standard real-time reverse transcription-polymerase chain reaction (RT-PCR) test for diagnosis of COVID-19 cases. Methods:  The rapid SARS-CoV-2 antigen detection test, Standard™ Q COVID-19 Ag kit (SD Biosensor®, Republic of Korea), was compared with the real-time RT-PCR test, Allplex™ 2019-nCoV Assay (Seegene®, Korea) for detection of SARS-CoV-2 in respiratory specimens. Four hundred fifty-four respiratory samples (mainly nasopharyngeal and throat swabs) were obtained from COVID-19 suspected cases and contact individuals, including pre-operative patients at Siriraj Hospital, Bangkok, Thailand during March–May 2020. Results:  Of 454 respiratory samples, 60 (13.2%) were positive, and 394 (86.8%) were negative for SARS-CoV-2 RNA by real-time RT-PCR assay. The duration from onset to laboratory test in COVID-19 suspected cases and contact individuals ranged from 0 to 14 days with a median of 3 days. The rapid SARS-CoV-2 antigen detection test’s sensitivity and specificity were 98.33% (95% CI, 91.06–99.96%) and 98.73% (95% CI, 97.06–99.59%), respectively. One false negative test result was from a sample with a high real-time RT-PCR cycle threshold (Ct), while five false positive test results were from specimens of pre-operative patients. Conclusions:  The rapid assay for SARS-CoV-2 antigen detection showed comparable sensitivity and specificity with the real-time RT-PCR assay. Thus, there is a potential use of this rapid and simple SARS-CoV-2 antigen detection test as a screening assay. Keywords:  COVID-19, SARS-CoV-2, Rapid antigen, RT-PCR, Thailand

*Correspondence: [email protected] 1 Department of Microbiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand Full list of author information is available at the end of the article

Background The Coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide since its first recorded case in the city of Wuhan, China in December 2019. According to the COVID-19

© The Author(s) 2020. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which